Extremely significant negative changes in Ultralife Corp (NASDAQ: ULBI) investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, and negative upside/downside volume developed.
Ultralife Corp (NASDAQ: ULBI) suffers from small negative changes in fundamentals: significant quarterly earnings deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of A. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, ULBI is expected to be a modest Value Builder.
Ultralife has a current Value Trend Rating of A (Highest Rating). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Ultralife has a neutral Appreciation Score of 55 but a very high Power Rating of 90, with the Highest Value Trend Rating the result.
Recent Price Action
On 9/6/24, Ultralife Corp (NASDAQ: ULBI) stock declined by -3.9%, closing at $9.23. However, trading volume in this decline was unusually low at 62% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -12.9% during the last week.
Be the first to comment